Browse Multiple myeloma topic

Subtopics (22)

• Care and treatment
• Case studies
• Complications
• Conferences, meetings and seminars
• Development and progression
• Diagnosis
• Drug therapy
• Genetic aspects
• Health aspects
• Patient outcomes
• Personal narratives
• Political aspects
• Prevention
• Prognosis
• Psychological aspects
• Reports
• Research
• Risk factors
• Rites, ceremonies and celebrations
• Statistics
• Technology application
• Training

Articles

Title	Author	Type	Date	Words
More Good News for Myeloma Patients Could Change Patterns of Treatment.			Dec 18, 2009	548
Research and Markets: Multiple Myeloma Therapeutics - US Market Trends & Analysis.			Dec 17, 2009	244
Seattle Genetics Announces Termination of Collaboration Agreement with Genentech for Dacetuzumab (SGN-40).			Dec 11, 2009	627
VELCADE[R] (Bortezomib) for Injection Based Therapy Delivers Sustained Overall Survival Advantage in Patients with Previously Untreated Multiple Myeloma.		Clinical report	Dec 8, 2009	1826
CombinatoRx Oncology Programs Demonstrate Synergistic Anti-Cancer Activity in Multiple Myeloma and Other B-Cell Malignancies.			Dec 8, 2009	516
The International Myeloma Foundation Says Important Studies May Offer New Approaches to Treating Multiple Myeloma.			Dec 8, 2009	849
VELCADE[R] (Bortezomib) for Injection Based Combinations Deliver Two-Year Overall Survival Rates of Up to 88 Percent in Patients with Previously Untreated Multiple Myeloma.		Clinical report	Dec 7, 2009	1842
Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab in Patients with Relapsed Multiple Myeloma.			Dec 7, 2009	1329
Seattle Genetics Reports Data from Dacetuzumab Phase Ib Combination Clinical Trials.			Dec 7, 2009	963
ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Multiple Myeloma.		Clinical report	Dec 7, 2009	1171
New 3-drug combo may effectively treat multiple myeloma.			Dec 6, 2009	421
VELCADE[R] (Bortezomib) for Injection Based Regimens Result in Lower Costs and Less Patient Burden Than Other Commonly Used Multiple Myeloma Treatment Regimens.			Dec 6, 2009	1946
Multiple Myeloma Research Consortium (MMRC) Honors Dana-Farber Cancer Institute with 2009 Center of the Year Award.			Dec 5, 2009	616
Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) Mourns Loss of Frederick Joseph.			Nov 30, 2009	372
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition.		Clinical report	Nov 24, 2009	518
Multiple Myeloma Research Consortium (MMRC) Unveils 16 Abstracts at ASH.			Nov 23, 2009	595
Millennium Initiates First Clinical Trial with the First Oral Proteasome Inhibitor.			Nov 18, 2009	1209
Guard Dog Brand Development Receives Honorable Mention Award for the Multiple Myeloma Research Foundation Corporate Identity Category in the 39th Annual Creativity Awards.			Nov 18, 2009	530
Guard Dog Brand Development Receives Three Silver Davey Awards in the Corporate Identity Category in the 5th Annual International Davey Awards for 2009.			Nov 18, 2009	461
Multiple Myeloma Research Foundation (MMRF) Names Robert Lucas Vice President of Development.			Nov 12, 2009	465
Research action plan launched; HEALTH.			Nov 5, 2009	105
UAMS gets $19m grant for multiple myeloma.	Carter, Mark		Nov 2, 2009	206
True Blues appealing to the Everton family.			Oct 31, 2009	201
Multiple Myeloma Research Foundation's (MMRF) Fall Gala Raises More Than $1.8 Million to Advance Cancer Research.			Oct 27, 2009	696
Cancer patients given a boost; A new treatment could give patients in the North East with certain types of cancer a greater chance of survival. Health Reporter HELEN RAE explains.			Oct 26, 2009	607
New Way of Therapy for Multiple Myeloma Offered.		Clinical report	Oct 25, 2009	465
Harvard Business School Awards MMRF Founder, CEO with Alumni Achievement Award.			Oct 22, 2009	404
New treatment for North's blood cancer victims.			Oct 17, 2009	213
United states : Onyx to buy Proteolix and get access to multiple myeloma drug.			Oct 16, 2009	368
Lisa to beat cancer for 5- km walk.			Oct 15, 2009	246
Seattle Genetics Announces Discontinuation of Dacetuzumab Phase IIb Diffuse Large B-Cell Lymphoma Clinical Trial.			Oct 5, 2009	749
Celiac disease: the great masquerader.	Gaby, Alan R.	Editorial	Oct 1, 2009	790
New hope in fight against blood cancer; GENETICS.			Sep 28, 2009	154
New hope in fight against blood cancer; GENETICS.			Sep 28, 2009	154
And in my bones a typhoon coming.			Sep 22, 2009	1018
Sports Legends and Broadcast Personalities Headline Multiple Myeloma Research Foundation's 13th Annual Fall Gala.			Sep 18, 2009	620
Lisa Ray says she didn't react after learning about her cancer.			Sep 14, 2009	245
ImmunoCellular Therapeutics Enters into Research and License Option Agreement with Roche Group.			Sep 9, 2009	672
United States : Clinical Data licenses cancer drug for $252M.			Aug 14, 2009	155
United States : Clinical Data, CombinatoRx Announced Collaboration And Licensing Agreement .			Aug 14, 2009	163
UNited States: CLDA/CRXX: Collaboration and Licensing Agreement for Multiple Myeloma Therapy.			Aug 14, 2009	268
Clinical Data, Inc. Announces Collaboration with CombinatoRx for the Development of Novel B-Cell Cancer Therapy.			Aug 13, 2009	812
United States : Clinical Data, Inc. Announces Collaboration with CombinatoRx for the Development of Novel B-Cell Cancer Therapy.		Clinical report	Aug 13, 2009	278
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis.			Aug 7, 2009	1418
Genzyme's Mozobil approved by EU for treating certain cancer patients requiring a stem cell transplant.			Aug 1, 2009	241
MMRC Multiple Myeloma Genomics Initiative First to Sequence Complete Myeloma Genomes.			Jul 27, 2009	835
FDA Accepts CyDex Pharmaceuticals' IND Application for Oncology Drug.		Clinical report	Jul 27, 2009	467
Daily pill may help treat blood cancer patients.			Jul 26, 2009	274
Gene variant linked to higher risk of common type of blood cancer.			Jul 21, 2009	464
United States: TrainingPeaks Selected by the Multiple Myeloma Research Foundation (MMRF) as Official Training Software of the MMRF Marathon and Half Marathon Program.			Jul 16, 2009	515
Multiple Myeloma Research Consortium (MMRC) Activates Clinical Trials 30-40 Percent Faster Than Industry Standard.			Jun 18, 2009	698
Ex-footie star launches wristband for blood cancer.			Jun 16, 2009	63
Pesticide exposure doubles one's blood disorder risk.			Jun 13, 2009	521
Research and Markets: A Global Strategic Business Report for Multiple Myeloma Therapeutics in Millions of US$.		Report	Jun 2, 2009	229
8th Annual Multiple Myeloma Research Foundation Chicago Awards Dinner Raises $900,000 for Next-Generation Cancer Treatments.			May 21, 2009	573
ImmunoCellular Therapeutics Granted Monoclonal Antibody Technology Patent.			Apr 29, 2009	628
Geron Presentations on Imetelstat (GRN163L) at the AACR 2009 Annual Meeting.			Apr 22, 2009	1774
New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor Presented at AACR.			Apr 21, 2009	638
The International Myeloma Foundation Says Medicare Decision to Cover PET Scans Can Improve Disease Staging and Treatment Planning.			Apr 6, 2009	607
The International Myeloma Foundation Says the Kennedy-Hutchison Cancer Bill Will Reinvigorate War on Cancer.			Mar 26, 2009	539
Dr. Brian Durie is the 2009 recipient of the prestigious Waldenstrom's Award for lifetime achievement in recognition of his contributions to finding a cure for multiple myeloma, a blood cancer.			Mar 16, 2009	67
New drug for blood cancer.			Mar 2, 2009	250
Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million to Aileron Therapeutics and Astex Therapeutics to Advance New Therapies for Multiple Myeloma.			Mar 2, 2009	805
Green tea blocks cancer drug.		Brief article	Mar 1, 2009	115
Dr. Brian Durie Receives the Prestigious Waldenstrom's Award in Recognition of His Many Contributions to the Field of Multiple Myeloma.			Feb 27, 2009	689
The International Myeloma Foundation - Webcasting Live from the Scientific Sessions at the XIIth International Myeloma Workshop.			Feb 26, 2009	516
70 Abstracts Evaluating the Potential of Celgene Products in Multiple Myeloma to Be Presented at the 12th International Myeloma Workshop.			Feb 26, 2009	245
Research and Markets: Anti-IL-6/R Antagonists: New Players in the Rheumatoid Arthritis Market.			Feb 16, 2009	310
Scots appeal for new cancer drug.			Jan 31, 2009	346
WORLD TODAY: U-turn over cancer drug.			Jan 30, 2009	76
WALES: THE RESEARCH IN DETAIL; FLEXSYS CANCER SCARE.			Jan 21, 2009	95
Multiple Myeloma Research Consortium (MMRC) and Merck Initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients.			Jan 16, 2009	803
FDA approves Genzyme's Mozobil for use in combination with G-CSF for treating patients with NHL and MM blood cancers.			Jan 1, 2009	343
GRAPESEED OIL HOPE FOR BLOOD CANCER PATIENTS; Diseased cells self-destruct.			Dec 31, 2008	345
Novel radiotherapy may revolutionise bone cancer treatment.			Dec 29, 2008	501
This woman has two months to live. But she must wait 25 days for drugs.			Dec 17, 2008	567
ImmunoGen, Inc. Announces Favorable IMGN901 Clinical Findings Reported at ASH Annual Meeting.		Clinical report	Dec 9, 2008	771
Gloucester Pharmaceuticals Announces Positive Results from Phase 1/2 Multiple Myeloma Clinical Trial at ASH.		Financial report	Dec 9, 2008	1020
CombinatoRx Presents New Data on B-Cell Malignancy Programs.			Dec 9, 2008	646
Scientists Report that T4 May Have Important Role in Multiple Myeloma.			Dec 8, 2008	1135
GPC Biotech Announces Presentation of New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor at the American Society of Hematology Annual Meeting.			Dec 8, 2008	599
Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug Trial in Patients with Multiple Myeloma.			Dec 8, 2008	1144
Multiple Myeloma Research Consortium (MMRC) Honors Dr. Andrzej Jakubowiak, University of Michigan with 2008 Center of the Year Award.			Dec 8, 2008	657
CombinatoRx Announces Availability of Abstracts on ASH Website.			Nov 24, 2008	599
'I've enough on my plate with fighting cancer, now I have to fight the NHS' Peter's appeal for treatment rejected by NHS Trust.			Nov 22, 2008	572
MULTIPLE MYELOMA; Peter's appeal for treatment rejected by NHS Trust.			Nov 22, 2008	86
Gloucester Pharmaceuticals to Present Positive Results from Multiple Romidepsin Clinical Trials at the ASH Annual Meeting.			Nov 20, 2008	686
The International Myeloma Foundation Announces New Three-Way Research Agreement with Nobel Prize Winner Luc Montagnier and Howard Urnovitz of Chronix Biomedical.			Nov 18, 2008	693
Multiple Myeloma Research Foundation's (MMRF) Annual Gala Raises More Than $1.5 Million to Advance Cancer Research.			Nov 4, 2008	502
Cut costs of drug, makers told, in NHS call for rethink.			Oct 29, 2008	281
NHS ban on miracle cancer drug; HEALTH.			Oct 28, 2008	116
NICE says No to another lifeline drug for cancer.			Oct 28, 2008	216
Geron Initiates Clinical Trial of GRN163L in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma.			Oct 20, 2008	809
Celgene Corporation and Acceleron Pharma Initiate Phase 2 Study of ACE-011 in Patients with Multiple Myeloma.			Oct 16, 2008	931
The Multiple Myeloma Research Consortium (MMRC) Announces Initiation of Phase 1B Study of Elotuzumab (HuLuc63) Monoclonal Antibody in Combination with REVLIMID and dexamethasone.			Oct 13, 2008	665
The International Myeloma Foundation Congratulates Friend and Collaborator Dr. Luc Montagnier for Being Awarded the Nobel Prize.			Oct 8, 2008	438
The International Myeloma Foundation Applauds Expansion of VELCADE(R) for Previously Untreated Patients in Europe and Canada.			Sep 29, 2008	486
The International Myeloma Foundation Says Life-Changing Benefits of REVLIMID(R) Recognized by the Prestigious Prix Galien USA Award 2008.		Disease/Disorder overview	Sep 25, 2008	457
EntreMed's ENMD-2076 Demonstrates Antitumor Activity in Multiple Myeloma Model.			Jun 1, 2008	497
Hycamtin shows activity in multiple myeloma.			May 1, 1998	118